Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells

Journal of Clinical Investigation

Volumn 79, Issue 4, 1987, Pages 1082-1090

  Zhu, L P ^a   Cupps, T R ^a   Whalen, G ^a   Fauci, A S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE GROWTH FACTOR; CYCLOPHOSPHAMIDE;

B LYMPHOCYTE; CELL CYCLE; CLINICAL ARTICLE; DRUG DOSE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE; THERAPY; WEGENER GRANULOMATOSIS;

EID: 0023268764     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI112922     Document Type: Article

References (0)